MolNFT v1 · #112437 · protein
Crystal structure of the roq domain of human roquin-2
4ZLC: “Crystal structure of the roq domain of human roquin-2”. X-ray diffraction, 3 pockets (best druggability 0.67). MolNFT v1 #112437 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4ZLC
- Type
- protein
- Length
- 606 residues
- Chains
- 4
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Roquin-2
- UniProt
- Q9HBD1
- Pockets
- 3 · best druggability 0.67
Structure
x-ray diffraction · 4 distinct chains · 62% helix, 7% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Roquin-2 | protein | 155 | 62% helix, 6% strand | Q9HBD1 |
| B | Roquin-2 | protein | 153 | 62% helix, 7% strand | Q9HBD1 |
| C | Roquin-2 | protein | 147 | 62% helix, 7% strand | Q9HBD1 |
| D | Roquin-2 | protein | 151 | 62% helix, 7% strand | Q9HBD1 |
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 620 | 0.67 | 0.76 | 81 | empty |
| 2 | 50 | 0.29 | 0.76 | 14 | empty |
| 3 | 52 | 0.27 | 0.74 | 13 | empty |
Interfaces
5 interfaces between chains.
- B–C · 995 Ų buried · 24 hydrogen bonds · protein-protein
- A–D · 948 Ų buried · 21 hydrogen bonds · protein-protein
- A–B · 503 Ų buried · 11 hydrogen bonds · protein-protein
- A–C · 111 Ų buried · 0 hydrogen bonds · protein-protein
- B–D · 68 Ų buried · 0 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9HBD1
- Elsewhere: RCSB PDB 4ZLC · PDBe 4ZLC · UniProt Q9HBD1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.